Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
Phase 3
Active, not recruiting
- Conditions
- Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicityLeft Ventricular DysfunctionChemotherapy Effect
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Giulio Stefanini
- Target Recruit Count
- 80
- Registration Number
- NCT05728632
- Locations
- 🇮🇹
IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
© Copyright 2025. All Rights Reserved by MedPath